Obesity Surgery

, Volume 23, Issue 5, pp 730–733

Swallowable Obalon® Gastric Balloons as an Aid for Weight Loss: A Pilot Feasibility Study

Authors

    • Department of Digestive DiseasesHospices Civils de Lyon, Hôpital E. Herriot
    • University Lyon 1
    • Labtau, INSERM 1032
  • Mostafa Ibrahim
    • Department of GastroenterologyHopital Erasme
  • Sophie Marjoux
    • Department of Digestive DiseasesHospices Civils de Lyon, Hôpital E. Herriot
  • Thierry Ponchon
    • Department of Digestive DiseasesHospices Civils de Lyon, Hôpital E. Herriot
    • University Lyon 1
  • Sonia Dugardeyn
    • Department of GastroenterologyHopital Erasme
  • Sabine Roman
    • Department of Digestive DiseasesHospices Civils de Lyon, Hôpital E. Herriot
    • University Lyon 1
    • Labtau, INSERM 1032
  • Jacques Deviere
    • Department of GastroenterologyHopital Erasme
Brief Communication

DOI: 10.1007/s11695-013-0927-x

Cite this article as:
Mion, F., Ibrahim, M., Marjoux, S. et al. OBES SURG (2013) 23: 730. doi:10.1007/s11695-013-0927-x

Abstract

The goal of this study was to evaluate the safety and the impact on weight loss of a new swallowable gastric balloon. In this prospective pilot study, 17 overweight or obese patients were included. Up to three balloons were ingested under fluoroscopic control. All balloons were removed by upper GI endoscopy, 12 weeks after the ingestion of the first balloon. 43 out of 44 attempts (98 %) to swallow a balloon were successful. Nausea and stomach pain were the most frequent side effects. Endoscopic procedures for balloon removal were uneventful. Weight loss was significant at weeks 4, 8, and 12. This pilot study showed no significant side effects induced by up to three balloons, and a significant weight loss.

Keywords

Intragastric balloonHumanObesity

Copyright information

© Springer Science+Business Media New York 2013